96 related articles for article (PubMed ID: 1800218)
1. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
2. Ferritin and malignant hemopathies. I. Ferritin in cerebrospinal fluid as an indicator of central nervous system leukemic involvement.
Dillmann E; López-Karpovitch X; Alvarez-Hernández X; Hurtado R; Córdova MS; González-Llaven J; Díaz-Maqueo JC
Rev Invest Clin; 1982; 34(2):95-8. PubMed ID: 7123032
[No Abstract] [Full Text] [Related]
3. Lactic acid concentration and acid-base balance in cerebrospinal fluid: observations of diagnostic importance in non-Hodgkin lymphoma.
Bjerrum OW; Borregaard N; Lage S
Neoplasma; 1987; 34(1):27-31. PubMed ID: 3104807
[TBL] [Abstract][Full Text] [Related]
4. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
5. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Groves MD
Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241
[No Abstract] [Full Text] [Related]
6. [Cerebrospinal fluid cytology in meningeal invasion of leukemia and malignant lymphoma. Reliable diagnosis by immunocytochemistry].
Bamborschke S; Huber M
Nervenarzt; 1992 Apr; 63(4):218-22. PubMed ID: 1594087
[TBL] [Abstract][Full Text] [Related]
7. [A case of adenoid cystic carcinoma manifesting Garcin's syndrome--effectiveness of cerebrospinal fluid ferritin as a tumor marker in malignant CNS involvement].
Sanjo N; Komiya T; Tamaki M; Arai M; Fukaya S
Rinsho Shinkeigaku; 1994 Aug; 34(8):838-41. PubMed ID: 7994994
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults. A review of 36 cases.
Mead GM; Kennedy P; Smith JL; Thompson J; Macbeth FR; Ryall RD; Williams CJ; Whitehouse JM
Q J Med; 1986 Jul; 60(231):699-714. PubMed ID: 3763820
[TBL] [Abstract][Full Text] [Related]
9. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
Schroers R; Baraniskin A; Heute C; Vorgerd M; Brunn A; Kuhnhenn J; Kowoll A; Alekseyev A; Schmiegel W; Schlegel U; Deckert M; Pels H
Eur J Haematol; 2010 Dec; 85(6):520-8. PubMed ID: 20727005
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
[TBL] [Abstract][Full Text] [Related]
13. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells.
Babusíková O; Zelezníková T
Neoplasma; 2004; 51(5):345-51. PubMed ID: 15640938
[TBL] [Abstract][Full Text] [Related]
14. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma.
Lim HY; Thiel E; Glantz MJ
Curr Opin Oncol; 2008 Sep; 20(5):495-501. PubMed ID: 19106650
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
Milman N; Vig L; Pedersen NS; Olsen TS
Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
[TBL] [Abstract][Full Text] [Related]
17. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid ferritin in malignant CNS involvement.
Zandman-Goddard G; Matzner Y; Konijn AM; Hershko C
Cancer; 1986 Sep; 58(6):1346-9. PubMed ID: 3742459
[TBL] [Abstract][Full Text] [Related]
20. [Neuromeningeal localizations in non-Hodgkin's lymphomas in adults].
Harousseau JL; Vallantin X; Tricot G; Gisselbrecht C; Jacquillat C
Sem Hop; 1983 Jan; 59(4):221-5. PubMed ID: 6301049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
